Irem Yucel

Array ( [id] => 3824459 [patent_doc_number] => 05759778 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Method of nucleic acid sequence selection' [patent_app_type] => 1 [patent_app_number] => 8/525140 [patent_app_country] => US [patent_app_date] => 1995-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6818 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759778.pdf [firstpage_image] =>[orig_patent_app_number] => 525140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931572 [patent_doc_number] => 05939275 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Mesangial cell lines as models for the study and treatment of diabetic tissue complications' [patent_app_type] => 1 [patent_app_number] => 8/522571 [patent_app_country] => US [patent_app_date] => 1995-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 20 [patent_no_of_words] => 19004 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939275.pdf [firstpage_image] =>[orig_patent_app_number] => 522571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4027821 [patent_doc_number] => 05994082 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Methods for the identification of inhibitors which suppress the activity of proteins displaying CIITA activity' [patent_app_type] => 1 [patent_app_number] => 8/519547 [patent_app_country] => US [patent_app_date] => 1995-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 10738 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 301 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994082.pdf [firstpage_image] =>[orig_patent_app_number] => 519547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811495 [patent_doc_number] => 05789164 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Agents and a method of chromosome preparation using protein phosphatase inhibitors induced premature chromosome condensation (PCC) technique' [patent_app_type] => 1 [patent_app_number] => 8/514727 [patent_app_country] => US [patent_app_date] => 1995-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 5808 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789164.pdf [firstpage_image] =>[orig_patent_app_number] => 514727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768352 [patent_doc_number] => 05849587 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells' [patent_app_type] => 1 [patent_app_number] => 8/488811 [patent_app_country] => US [patent_app_date] => 1995-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 31 [patent_no_of_words] => 12641 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849587.pdf [firstpage_image] =>[orig_patent_app_number] => 488811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3809066 [patent_doc_number] => 05811406 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Dry powder formulations of polynucleotide complexes' [patent_app_type] => 1 [patent_app_number] => 8/482254 [patent_app_country] => US [patent_app_date] => 1995-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 32 [patent_no_of_words] => 6983 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811406.pdf [firstpage_image] =>[orig_patent_app_number] => 482254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4218355 [patent_doc_number] => 06040183 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Helper virus-free AAV production' [patent_app_type] => 1 [patent_app_number] => 8/484515 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6128 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040183.pdf [firstpage_image] =>[orig_patent_app_number] => 484515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876821 [patent_doc_number] => 05747470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA' [patent_app_type] => 1 [patent_app_number] => 8/484518 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5885 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747470.pdf [firstpage_image] =>[orig_patent_app_number] => 484518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932521 [patent_doc_number] => 05972600 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Separation of active complexes' [patent_app_type] => 1 [patent_app_number] => 8/482110 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 19 [patent_no_of_words] => 7188 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972600.pdf [firstpage_image] =>[orig_patent_app_number] => 482110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1532176 [patent_doc_number] => 06410326 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Method for inhibiting human tumor cells' [patent_app_type] => B1 [patent_app_number] => 08/486683 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 54 [patent_no_of_words] => 36653 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410326.pdf [firstpage_image] =>[orig_patent_app_number] => 08486683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3955752 [patent_doc_number] => 05935935 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Adenoviral vectors for treatment of hemophilia' [patent_app_type] => 1 [patent_app_number] => 8/484891 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 74 [patent_no_of_words] => 29367 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935935.pdf [firstpage_image] =>[orig_patent_app_number] => 484891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924515 [patent_doc_number] => 05876962 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors' [patent_app_type] => 1 [patent_app_number] => 8/486101 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 43 [patent_no_of_words] => 18740 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876962.pdf [firstpage_image] =>[orig_patent_app_number] => 486101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4057720 [patent_doc_number] => 05866131 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Recombinant vaccine' [patent_app_type] => 1 [patent_app_number] => 8/473301 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 22 [patent_no_of_words] => 9136 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866131.pdf [firstpage_image] =>[orig_patent_app_number] => 473301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932536 [patent_doc_number] => 05972601 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Methods and kits for determining the pen polymorphism of human platelet membrane glycoprotein IIIA' [patent_app_type] => 1 [patent_app_number] => 8/484201 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6316 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972601.pdf [firstpage_image] =>[orig_patent_app_number] => 484201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686014 [patent_doc_number] => 05695967 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Method for stably cloning large repeating units of DNA' [patent_app_type] => 1 [patent_app_number] => 8/487989 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5054 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695967.pdf [firstpage_image] =>[orig_patent_app_number] => 487989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741875 [patent_doc_number] => 05786340 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'Gene transfer to the intestine' [patent_app_type] => 1 [patent_app_number] => 8/472163 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 8156 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786340.pdf [firstpage_image] =>[orig_patent_app_number] => 472163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935455 [patent_doc_number] => 05981216 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same' [patent_app_type] => 1 [patent_app_number] => 8/483813 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6760 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981216.pdf [firstpage_image] =>[orig_patent_app_number] => 483813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3783948 [patent_doc_number] => 05840483 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Method of maintaining a desired recombinant gene in a genetic population of cells' [patent_app_type] => 1 [patent_app_number] => 8/473926 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 20462 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840483.pdf [firstpage_image] =>[orig_patent_app_number] => 473926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4156347 [patent_doc_number] => 06124448 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Nucleic acid primers and probes for the mammalian OB gene' [patent_app_type] => 1 [patent_app_number] => 8/488208 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 61607 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124448.pdf [firstpage_image] =>[orig_patent_app_number] => 488208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3855194 [patent_doc_number] => 05705385 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer' [patent_app_type] => 1 [patent_app_number] => 8/485458 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 11859 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705385.pdf [firstpage_image] =>[orig_patent_app_number] => 485458 [rel_patent_id] =>[rel_patent_doc_number] =>)